Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk of elevated intraocular pressure after topical periocular corticosteroids
2020-000252-35Phase 4Completed
- Sponsor
- Lone Skov
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of hydrocortisone butyrate and hydrocortisone in ocular hypertension, atopic dermatitis (AD) and healthy participant (not a disease) (2 arms), sponsored by Lone Skov. Primary endpoint: Total change in intraocular pressure. Started Feb 2020; status: completed.
02
Drugs
hydrocortisone butyratehydrocortisone
03
Conditions
ocular hypertensionatopic dermatitis (AD)healthy participant (not a disease)
Beyond the preview
Go deeper on 2020-000252-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000252-35.